4.8 Article

Distinguishing nanoparticle drug release mechanisms by asymmetric flow field-flow fractionation

Journal

JOURNAL OF CONTROLLED RELEASE
Volume 352, Issue -, Pages 485-496

Publisher

ELSEVIER
DOI: 10.1016/j.jconrel.2022.10.034

Keywords

Polymeric nanoparticles; Lipophilic drugs; Formulation purity; Drug distribution; Drug release mechanism; Nanoparticle quantification

Funding

  1. U.S. Department of Agriculture [2018-67022-27969, 17545]
  2. FMC Corporation through the New Investigator Award

Ask authors/readers for more resources

This research presents the development and application of a multi-detector AF4 method to study drug loading and release from polymeric nanoparticles. By using multiple online detectors, the researchers were able to determine the release mechanism and draw important conclusions.
This research demonstrates the development, application, and mechanistic value of a multi-detector asymmetric flow field-flow fractionation (AF4) approach to acquire size-resolved drug loading and release profiles from polymeric nanoparticles (NPs). AF4 was hyphenated with multiple online detectors, including dynamic and multi-angle light scattering for NP size and shape factor analysis, fluorescence for drug detection, and total organic carbon (TOC) to quantify the NPs and dissolved polymer in nanoformulations. The method was demonstrated on poly(lactic-co-glycolic acid) (PLGA) NPs loaded with coumarin 6 (C6) as a lipophilic drug surrogate. The bulk C6 release profile using AF4 was validated against conventional analysis of drug extracted from the NPs and complemented with high performance liquid chromatography - quadrupole time-of-flight (HPLC-QTOF) mass spectrometry analysis of oligomeric PLGA species. Interpretation of the bulk drug release profile was ambiguous, with several release models yielding reasonable fits. In contrast, the size-resolved release profiles from AF4 provided critical information to confidently establish the release mechanism. Specifically, the C6-loaded NPs exhibited size-independent release rate constants and no significant NP size or shape trans-formations, suggesting surface desorption rather than diffusion through the PLGA matrix or erosion. This conclusion was supported through comparative experimental evaluation of PLGA NPs carrying a fully entrapped drug, enrofloxacin, which showed size-dependent diffusive release, along with density functional theory (DFT) calculations indicating a higher adsorption affinity of C6 onto PLGA. In summary, the development of the size -resolved AF4 method and data analysis framework fulfills salient analytical gaps to determine drug localization and release mechanisms from nanomedicines.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available